Thromb Haemost 1999; 82(02): 850-857
DOI: 10.1055/s-0037-1615922
Research Article
Schattauer GmbH

New Discoveries with Mice Mutant in Endothelial and Platelet Selectins

Daqing W. Hartwell
1   The Center for Blood Research, Department of Pathology, Harvard Medical School, Boston, MA, USA
,
Denisa D. Wagner
1   The Center for Blood Research, Department of Pathology, Harvard Medical School, Boston, MA, USA
› Author Affiliations
Further Information

Publication History

Publication Date:
09 December 2017 (online)

Introduction

The selectin family of adhesion receptors consists of three members: P-, E-, and L-selectin. P-selectin is constitutively present in the α-granules of platelets and Weibel-Palade bodies of endothelial cells and is rapidly translocated to the cell surface upon activation. E-selectin is synthesized and expressed by activated endothelial cells, whereas L-selectin is constitutively expressed by leukocytes. All three selectins support the rolling of leukocytes on endothelium, which is a prerequisite to firm adhesion and extravasation of leukocytes mediated by integrins and members of the immunoglobulin superfamily.1,2 More recently, it has been demonstrated that P- and E-selectin also support platelet rolling in venules, which will be discussed below. In addition, P-selectin expressed on the surface of activated platelets also mediates platelet-leukocyte adhesion.3,4

Since the discovery of the selectins, considerable efforts have been devoted to uncover the functions of these molecules. The development of genetically engineered animals deficient in one or more of the adhesion receptors has provided a unique opportunity and an alternative approach to antibody-blocking experiments for defining the contribution of each of the molecules in normal physiology and pathological conditions. At this time, mice deficient in a single selectin, all combinations of two of the selectins, and all three selectins have been produced by gene targeting.5-10 In this chapter, we will discuss some of the recent findings obtained using mice deficient in P-selectin alone (P-/-), both P- and E-selectin (P/E-/-), and mice expressing Pselectin with a deleted cytoplasmic domain (ΔCT).

 
  • References

  • 1 Springer TA. Traffic signals on endothelium for lymphocyte recirculation and leukocyte emigration. Annu Rev Physiol 1995; 57: 827-872.
  • 2 Frenette PS, Wagner DD. Insights into selectin function from knockout mice. Thromb Haemost 1997; 78: 64-69.
  • 3 Larsen E, Celi A, Gilbert GE, Furie BC, Erban JK, Bonfanti R, Wagner DD, Furie B. PADGEM protein: a receptor that mediates the interaction of activated platelets with neutrophils and monocytes. Cell 1989; 59: 305-312.
  • 4 Hamburger SA, McEver RP. GMP-140 Mediates adhesion of stimulated platelets to neutrophils. Blood 1990; 75: 550-554.
  • 5 Mayadas TN, Johnson RC, Rayburn H, Hynes RO, Wagner DD. Leukocyte rolling and extravasation are severely compromised in P-selectin-deficient mice. Cell 1993; 74: 541-554.
  • 6 Arbones ML, Ord DC, Ley K, Ratech H, Maynard-Curry C, Otten G, Capon DJ, Tedder TF. Lymphocyte homing and leukocyte rolling and migration are impaired in L-selectin-deficient mice. Immunity 1994; 1: 247-260.
  • 7 Labow MA, Norton CR, Rumberger JM, Lombard-Gillooly KM, Shuster DJ, Hubbard J, Bertko R, Knaack PA, Terry RW, Harbison ML, Kontgen F, Stewart CL, McIntyre KW, Will PC, Burns DK, Wolitzky BA. Characterization of E-selectin-deficient mice: demonstration of overlapping function of the endothelial selectins. Immunity 1994; 1: 709-720.
  • 8 Frenette PS, Mayadas TN, Rayburn H, Hynes RO, Wagner DD. Susceptibility to infection and altered hematopoiesis in mice deficient in both P- and E-selectins. Cell 1996; 84: 563-574.
  • 9 Bullard DC, Kunkel EJ, Kubo H, Hicks MJ, Lorenzo I, Doyle NA, Doerschuk CM, Beaudet AL. Infectious susceptibility and severe deficiency of leukocyte rolling and recruitment in E-selectin and P-selectin double mutant mice. J Exp Med 1996; 183: 2329-2336.
  • 10 Robinson SD, Frenette PS, Rayburn H, Cummiskey M, Ulman-Cullere M, Wagner DD, Hynes RO. Generation of double- and triple-deficient selectin mice. Microcirculation 1997; 4: 131.
  • 11 Johnson RC, Mayadas TN, Frenette PS, Mebius RE, Subrananiam M, Lacasce A, Hynes RO, Wagner DD. Blood cell dynamics in P-selectin-deficient mice. Blood 1995; 86: 1106.
  • 12 Kunkel EJ, Ley K. Distinct phenotype of E-selectin-deficient mice. E-selectin is required for slow leukocyte rolling in vivo. Circ Res 1996; 79: 1196-1204.
  • 13 Jung U, Norman KE, Scharffetter-Kochanek K, Beaudet AL, Ley K. Transit time of leukocytes rolling through venules controls cytokine-induced inflammatory cell recruitment in vivo . J Clin Invest 1998; 102: 1526-1533.
  • 14 Munoz FM, Hawkins EP, Bullard DC, Beaudet AL, Kaplan SL. Host defense against systemic infection with Streptococcus pneumoniae is impaired in E-, P-, and E-/P-selectin-deficient mice. J Clin Invest 1997; 100: 2099-2106.
  • 15 Frenette PS, Johnson RC, Hynes RO, Wagner DD. Platelets roll on stimulated endothelium in vivo: An interaction mediated by endothelial P-selectin. Proc Natl Acad Sci USA 1995; 92: 7450-7454.
  • 16 Frenette PS, Moyna C, Hartwell DW, Lowe JB, Hynes RO, Wagner DD. Platelet-endothelial interactions in inflamed mesenteric venules. Blood 1998; 91: 1318-1324.
  • 17 Moore KL, Patel KD, Bruehl RE, Li F, Johnson DA, Lichenstein HS, Cummings RD, Bainton DF, McEver RP. P-selectin glycoprotein ligand-1 mediates rolling of human neutrophils on P-selectin. J Cell Biol 1995; 128: 661-671.
  • 18 Sako D, Chang X-J, Barone KM, Vachino G, White HM, Shaw G, Veldman GM, Bean KM, Ahern TJ, Furrie B, Cumming DA, Larsen GR. Expression cloning of a functional glycoprotein ligand for P-selectin. Cell 1993; 75: 1179-1186.
  • 19 Frenette PS, Denis C, Subbarao S, Vestweber D, Wagner DD. P-selectin glycoprotein ligand-1 is expressed on platelets and mediates platelet-endothelial interactions in vivo. Blood 1998; 92: 348a.
  • 20 Lopez JA, Romo GM, Dong J-F, Schade A, Kansas GS, McIntire LV, Berndt MC. The glycoprotein Ib-IX-V complex is a platelet counter-receptor for P-selectin. Blood 1998; 92: 703a.
  • 21 Ward CM, Andrews RK, Smith AI, Berndt MC. Mocarhagin, a novel cobra venom metalloproteinase, cleaves the platelet von Willebrand factor receptor glycoprotein Ibalpha. Identification of the sulfated tyrosine/anionic sequence Tyr-276-Glu-282 of glycoprotein Ibalpha as a binding site for von Willebrand factor and alpha-thrombin. Biochemistry 1996; 35: 4929-4938.
  • 22 Sako D, Comess KM, Barone KM, Camphausen RT, Cumming DA, Shaw GD. A sulfated peptide segment at the amino terminus of PSGL-1 is critical for P-selectin binding. Cell 1995; 83: 1-20.
  • 23 Catalina MD, Carroll MC, Arizpe A, Takashima P, Estess P, Siegelman MH. The route of antigen entry determines the requirement for L-selectin during immune responses. J Exp Med 1996; 184: 2341-2351.
  • 24 Tedder TF, Steeber DA, Pizcueta P. L-selectin-deficient mice have impaired leukocyte recruitment into inflammatory sites. J Exp Med 1995; 181: 2259-2264.
  • 25 Diacovo TG, Puri KD, Warnock RA, Springer TA, von Andrian UH. Platelet-mediated lymphocyte delivery to high endothelial venules. Science 1996; 273: 252-255.
  • 26 Diacovo TG, Catalina MD, Siegelman MH, von Andrian UH. Circulating activated platelets reconstitute lymphocyte homing and immunity in L-selectin-deficient mice. J Exp Med 1998; 187: 197-204.
  • 27 Michelson AD, Barnard MR, Hechtman HB, MacGregor H, Connolly RJ, Loscalzo J, Valeri CR. In vivo tracking of platelets: circulating degranulated platelets rapidly lose surface P-selectin but continue to circulate and function. Proc Natl Acad Sci USA 1996; 93: 11877-11882.
  • 28 Berger G, Hartwell DW, Wagner DD. P-selectin and platelet clearance. Blood 1998; 92: 4446-4452.
  • 29 Papayannopoulou T, Nakamoto B. Peripheralization of hemopoietic progenitors in primates treated with anti-VLA4 integrin. Proc Natl Acad Sci USA 1993; 90: 9374-9378.
  • 30 Papayannopoulou T, Craddock C, Nakamoto B, Priestley GV, Wolf NS. The VLA-4/VCAM-1 adhesion pathway defines contrasting mechanisms of lodgement of transplanted murine hemopoietic progenitors between bone marrow and spleen. Proc Natl Acad Sci USA 1995; 92: 9647-9651.
  • 31 Zannettino AC, Berndt MC, Butcher C, Butcher EC, Vasas MA, Simmons PJ. Primitive human hematopoietic progenitors adhere to P-selectin (CD62P). Blood 1995; 85: 3466-3477.
  • 32 Jacobsen K, Kravitz J, Kincade PW, Osmond DG. Adhesion receptors on bone marrow stromal cells: in vivo expression of vascular cell adhesion molecule-1 by reticular cells and sinusoidal endothelium in normal and γ-irradiated mice. Blood 1996; 87: 73-82.
  • 33 Schweitzer KM, Drager AM, van der Valk P, Thijsen SF, Zevenbergen A, Theijsmeijer AP, van der Schoot CE, Langenhuijsen MM. Constitutive expression of E-selectin and vascular cell adhesion molecule-1 on endothelial cells of hematopoietic tissues. Am J Pathol 1996; 148: 165-175.
  • 34 Mazo IB, Gutierrez-Ramos JC, Frenette PS, Hynes RO, Wagner DD, von Andrian UH. Hematopoietic progenitor cell rolling in bone marrow microvessels: parallel contributions by endothelial selectins and vascular cell adhesion molecule 1. J Exp Med 1998; 188: 465-474.
  • 35 Frenette PS, Subbarao S, Mazo IB, von Andrian UH, Wagner DD. Endothelial selectin and vascular cell adhesion molecule-1 promote hematopoietic progenitor homing to bone marrow. Proc Natl Acad Sci USA 1998; 95: 14423-14428.
  • 36 Subramaniam M, Saffaripour S, Watson SR, Mayadas TN, Hynes RO, Wagner DD. Reduced recruitment of inflammatory cells in a contact hypersensitivity response in P-selectin-deficient mice. J Exp Med 1995; 181: 2277-2282.
  • 37 Staite ND, Justen JM, Sly LM, Beaudet AL, Bullard DC. Inhibition of delayed-type contact hypersensitivity in mice deficient in both E-selectin and P-selectin. Blood 1996; 88: 2973-2979.
  • 38 Austrup F, Vestweber D, Borges E, Lohning M, Brauer R, Herz U, Renz H, Hallmann R, Scheffold A, Radbruch A, Hamann A. P- and E-selectin mediate recruitment of T-helper-1 but not T-helper-2 cells into inflamed tissues. Nature 1997; 385: 81-83.
  • 39 Disdier M, Morrisey JH, Fugate RD, Bainton DF, McEver RP. Cytoplasmic domain of P-selectin (CD62) contains the signal for sorting into the regulated secretory pathway. Mol Biol Cell 1992; 3: 309-321.
  • 40 Subramaniam M, Koedam JA, Wagner DD. Divergent fates of P- and E-selectin after their expression on the plasma membrane. Mol Biol Cell 1993; 4: 791-801.
  • 41 Setiadi H, Disdier M, Green SA, Canfield WM, McEver RP. Residues throughout the cytoplasmic domain affect the internalization efficiency of P-selectin. J Biol Chem 1995; 270: 26818-26826.
  • 42 Norcott JP, Solari R, Cutler DF. Targeting of P-selectin to two regulated secretory organelles in PC12 cells. J Cell Biol 1996; 134: 1229-1240.
  • 43 Hartwell DW, Mayadas TN, Berger G, Frenette PS, Rayburn H, Hynes RO, Wagner DD. Role of P-selectin cytoplasmic domain in granular targeting in vivo and in early inflammatory responses. J Cell Biol 1998; 143: 1129-1141.
  • 44 Gamble JR, Skinner MP, Berndt MC, Vadas MA. Prevention of activated neutrophil adhesion to endothelium by soluble adhesion protein GMP-140. Science 1990; 249: 414-417.
  • 45 Wong CS, Gamble JR, Skinner MP, Lucas CM, Berndt MC, Vadas MA. Adhesion protein GMP-140 inhibits superoxide anion release by human neutrophils. Proc Natl Acad Sci USA 1991; 88: 2397-2401.
  • 46 Nguyen M, Strubel NA, Bischoff J. A role for sialyl Lewis-X/A glycoconjugates in capillary morphogenesis. Nature 1993; 365: 267-269.
  • 47 Koch AE, Halloran MM, Haskell CJ, Shah MR, Polverini PJ. Angiogenesis mediated by soluble forms of E-selectin and vascular cell adhesion molecule-1. Nature 1995; 376: 517-520.
  • 48 Steegmaier M, Levinovitz A, Isenmann S, Borges E, Lenter M, Kocher HP, Kleuser B, Vestweber D. The E-selectin-ligand ESL-1 is a variant of a receptor for fibroblast growth factor. Nature 1995; 373: 615-620.
  • 49 Budson AE, Ko L, Brasel C, Bischoff J. The angiogenesis inhibitor AGM-1470 selectively increases E-selectin. Biochem Biophys Res Commun 1996; 225: 141-145.
  • 50 Gerritsen ME, Shen CP, Atkinson WJ, Padgett RC, Gimbrone MAJ, Milstone DS. Microvascular endothelial cells from E-selectin-deficient mice form tubes in vitro . Lab Invest 1996; 75: 175-184.
  • 51 Hartwell DW, Butterfield CE, Frenette PS, Kenyon BM, Hynes RO, Folkman J, Wagner DD. Angiogenesis in P- and E-selectindeficient mice. Microcirculation 1998; 5: 173-178.
  • 52 Aruffo A, Dietsch MT, Wan H, Hellstrom KE, Hellstrom I. Granule membrane protein 140 (GMP-140) binds to carcinomas and carcinoma-derived cell lines. Proc Natl Acad Sci USA 1992; 89: 2292-2296.
  • 53 Stone JP, Wagner DD. P-selectin mediates adhesion of platelets to neuroblastoma and small cell lung cancer. J Clin Invest 1993; 92: 804-813.
  • 54 Nakayama T, Watamabe M, Katsumata T, Teramoto T, Kitajima M. Expression of sialyl Lewis (a) as a new prognostic factor for patients with advanced colorectal carcinoma. Cancer 1995; 75: 2051-2056.
  • 55 Ogawa JI, Inoue H, Koide S. Alpha-2, 3-sialyltransferase type 3N and alpha-1, 3-fucosyltransferase type VII are related to sialyl Lewis (x) synthesis and patient survival from lung carcinoma. Cancer 1997; 79: 1678-1685.
  • 56 Biancone L, Araki M, Araki K, Vassalli P, Stamenkovic I. Redirection of tumor metastasis by expression of E-selectin in vivo. J Exp Med 1996; 183: 581-587.
  • 57 Kim YJ, Borsig L, Varki NM, Varki A. P-selectin deficiency attenuates tumor growth and metastasis. Proc Natl Acad Sci USA 1998; 95: 9325-9330.
  • 58 Ross R. Atherosclerosis-an inflammatory disease. N Engl. J. Med 1999; 340: 115-126.
  • 59 Nageh MF, Sandberg ET, Marotti KR, Lin AH, Melchior EP, Bullard DC, Beaudet AL. Deficiency of inflammatory cell adhesion molecules protects against atherosclerosis in mice. Arterioscler Thromb Vasc Biol 1997; 17: 1517-1520.
  • 60 Ishibashi S, Goldstein JL, Brown MS, Herz J, Burns DL. Massive xanthomatosis and atherosclerosis in cholesterol-fed low density lipoprotein receptor-negative mice. J Clin Invest 1994; 93: 1885-1893.
  • 61 Johnson RC, Chapman SM, Dong ZM, Ordovas JM, Mayadas TN, Herz J, Hynes RO, Schaefer EJ, Wagner DD. Absence of P-selectin delays fatty streak formation in mice. J Clin Invest 1997; 99: 1037-1043.
  • 62 Dong ZM, Chapman MS, Brown AA, Frenette PS, Hynes RO, Wagner DW. The combined role of P- and E-selectin in atherosclerosis. J Clin Invest 1998; 102: 145-152.
  • 63 Breslow JL. Mouse models of atherosclerosis. Science 1996; 272: 685-688.
  • 64 Main IW, Nikolic-Paterson DJ, Atkins RC. T cells and macrophages and their role in renal injury. Semin Nephrol 1992; 12: 396-407.
  • 65 Lefkowith JB. Leukocyte migration in immune complex glomerulonephritis: role of adhesion receptors. Kidney Int 1997; 39: 555-565.
  • 66 Mayadas TN, Mendrick DL, Brady HR, Tang T, Papayianni A, Assmann KJM, Wagner DD, Hynes RO, Cotran RS. Acute passive anti-glomerular basement membrane nephritis in P-selectindeficient mice. Kidney Int 1996; 49: 1342-1349.
  • 67 Papayianni A, Serhan CN, Brady HR. Lipoxin A4 and B4 inhibit leukotriene-stimulated interactions of human neutrophils and endothelial cells. J Immunol 1996; 156: 2264-2272.
  • 68 Papayianni A, Rennke H, Serhan CN, Brady HR. Platelet-leukocyte adhesion through P-selectin facilitates transcellular lipoxin bio-synthesis in acute glomerulonephritis. Kidney Int 1995; 47: 1295-1302.
  • 69 Rosenkranz AR, Mendrick DL, Cotran RS, Mayadas TN. P-selectin deficiency exacerbates experimental glomerulonephritis: a protective role for endothelial P-selectin in inflammation. J Clin Invest. In press.